What does Alaunos Therapeutics, Inc. do?

Jun 22 2025 06:34 PM IST
share
Share Via
Alaunos Therapeutics, Inc. is a micro-cap biopharmaceutical company focused on developing cancer therapies in the immuno-oncology sector. As of March 2025, it reported net sales of $0 million and a net loss of $1 million, with a market cap of $6 million.
Overview:
Alaunos Therapeutics, Inc. is a biopharmaceutical company focused on developing cancer therapies in the immuno-oncology sector, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025)
Market cap: USD 6.00 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.30
Return on Equity: -384.78%
Price to Book: 5.67

Contact Details:
Address: One First Avenue Parris Building 34 Navy Yard Plaza BOSTON MA : 02129
Tel: ['1 617 2591970', '1 617 5021881']
Fax: 1 617 2412855
Website: http://www.ziopharm.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Alaunos Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 08:48 AM IST
share
Share Via
How big is Alaunos Therapeutics, Inc.?
Jun 22 2025 05:55 PM IST
share
Share Via